Abstract
Endophthalmitis is the acute suppurative inflammation in uvea and retina, with rapid onset, severe symptoms, and poor prognosis. Definite diagnosis and effective treatment on early stage play key roles in the prognosis. As endogenous endophthalmitis originates from suppurative inflammation in other parts of our body with hidden primary lesions, and is found less common in clinical practice, ophthalmologists might easily confuse it with uveitis caused by the immune disease, which not only causes a high misdiagnosis rate, but also delays the best opportunity for diagnosis and treatment. Endogenous endophthalmitis is a focus secondary to systemic infection, requiring ophthalmologists to strengthen the understanding of systemic infection and detailed history taking, to learn that whether the primary lesions exist or not? Where is the primary lesion? Which kind of pathogen causes the infection? How to apply the antibiotics? This section analyzes the cases of endogenous endophthalmitis in Tongren Hospital, and summarizes the experience in etiology, clinical manifestation, diagnosis points, treatment, prognosis, etc. of endogenous endophthalmitis. Ophthalmologists are supposed to take endogenous endophthalmitis from the perspective of integrative medicine, identify endogenous endophthalmitis through the history and pathogen examination, and clarify the cause and pathogens, and thus target the selection of antibiotics, taking the systemic inflammation control into account. Ophthalmologists should strengthen the understanding of endogenous endophthalmitis, make diagnosis at early stage and apply the effective drug timely, and improve the prognosis of endogenous endophthalmitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Connell PP, O’Neill EC, Fabinyi D, et al. Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye (Lond). 2011;25(1):66–72.
Jackson TL, Eykyn SJ, Graham EM, et al. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48(4):403–23.
Chung KS, Kim YK, Song YG, et al. Clinical review of endogenous endophthalmitis in Korea: a 14-year review of culture positive cases of two large hospitals. Yonsei Med J. 2011;52(4):630–4.
Binder MI, Chua J, Kaiser PK, et al. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore). 2003;82(2):97–105.
Lim HW, Shin JW, Cho HY, et al. Endogenous endophthalmitis in the Korean population: a six-year retrospective study. Retina. 2014;34(3):592–602.
Pinna A, Cara F, Zanetti S, et al. Endogenous Rhodotorula minuta and Candida albicans endophthalmitis in an injecting drug user. Br J Ophthalmol. 2001;85(6):759.
Chhablani J. Fungal endophthalmitis. Exp Rev Anti Infect Ther. 2011;9(12):1191–201.
Schiedler V, Scott IU, Flynn HW. Culture-proven endogenous endophthalmitis clinical features and visual acuity outcomes. Am J ophthalmol. 2004;137(4):725–31.
Chen KJ, Wu WC, Sun MH, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;154(1):213–4.
Arevalo JF, Jap A, Chee SP, et al. Endogenous endophthalmitis in the developing world. Int Ophthalmol Clin. 2010;50(2):173–87.
Sridhar J, Flynn HW Jr, Kuriyan AE, et al. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect. 2013;3(1):60.
Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis. 2000;30(1):14–8.
Congrong L, Shaohua P, Dong L, et al. A hospital acquired infection of deep fungus: a clinical investigation and drug resistance. Chin J Nosocomiol. 2002;12(7):485–7.
Pfaller MA, Messer SA, Hollis RJ, et al. Trends in species distribution and susceptibility to fluconazole among blood steam isolates of Candida species in the United states. Diagn Microbiol Infect Dis. 1999;33(4):217–22.
Leibovitch I, Lai T, Raymond G, et al. Endogenous endophthalmitis: a 13-year review at a tertiary hospital in South Australia. Scand J Infect Dis. 2005;37(3):184–9.
Wong JS, Chan TK, Lee HM. Endogenous bacterial endophthalmitis. An east Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology. 2000;107(8):1483–91.
Peizeng Y. Clinical uveitis. Beijing: People’s Medical Publishing House; 2004. p. 677–8.
Cornut PL, Chiquet C. Endogenous bacterial endophthalmitis. J Fr Ophthalmol. 2011;34(1):51–7.
Lee JH, Kim JS, Park YH. Diagnosis and treatment of postpartum Candida endophthalmitis. J Obstet Gynaecol Res. 2012;38(9):1220–2.
Tanaka M, Kobayashi Y, Takebayashi H, et al. Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis: a retrospective 12-year study of 79 eyes of 46 patients. Retina. 2001;21(3):203–9.
Okada AA, Johnson RP, Liles WC. Endogenous bacterial endophthalmitis. Report of a 10-year retrospective study. Ophthalmology. 1994;101(5):832–8.
Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol. 1986;31(2):81–101.
Christmas NJ, Smiddy WE. Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers. 1996;27(12):1012–8.
Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis. 1990;12(2):308–29.
Akler ME, Vellend H, McNeely DM, et al. Use of fluconazole in the treatment of candidal endophthalmitis. Clin Infect Dis. 1995;20(3):657–64.
Riddell J 4th, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis. 2011;52(5):648–53.
Penk A, Pittrow L. Status of fluconazole in the therapy of endogenous Candida endophthalmitis. Mycoses. 1998;2:41–4.
Michal W, Olena W, Wojciech O. Bilateral endogenous fungal endophthalmitis. Int Ophthalmol. 2014;34(2):321–5.
Shen X, Xu G. Vitrectomy for endogenous fungal endophthalmitis. Ocul Immunol Inflamm. 2009;17(3):148–52.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China
About this chapter
Cite this chapter
Wang, H., Wei, W., Shen, L., Hong, Y. (2020). Endogenous Endophthalmitis from the Prospective of Integration Medicine. In: Wang, N. (eds) Integrative Ophthalmology. Advances in Visual Science and Eye Diseases, vol 3. Springer, Singapore. https://doi.org/10.1007/978-981-13-7896-6_34
Download citation
DOI: https://doi.org/10.1007/978-981-13-7896-6_34
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7895-9
Online ISBN: 978-981-13-7896-6
eBook Packages: MedicineMedicine (R0)